199 related articles for article (PubMed ID: 32908208)
1. Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs.
Angrimani DSR; Brito MM; Rui BR; Nichi M; Vannucchi CI
Sci Rep; 2020 Sep; 10(1):14834. PubMed ID: 32908208
[TBL] [Abstract][Full Text] [Related]
2. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
[TBL] [Abstract][Full Text] [Related]
3. Endocrine, prostatic vascular, and proapoptotic changes in dogs with benign prostatic hyperplasia treated medically or surgically.
Lima CB; Angrimani DSR; Flores RB; Vannucchi CI
Domest Anim Endocrinol; 2021 Apr; 75():106601. PubMed ID: 33333452
[TBL] [Abstract][Full Text] [Related]
4. Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy.
Sirinarumitr K; Johnston SD; Kustritz MV; Johnston GR; Sarkar DK; Memon MA
J Am Vet Med Assoc; 2001 Apr; 218(8):1275-80. PubMed ID: 11330612
[TBL] [Abstract][Full Text] [Related]
5. Changes in the Serum Prostatic Biomarkers During the Treatment of Benign Prostatic Hyperplasia with a 5alpha-reductase Inhibitor: Finasteride.
Golchin-Rad K; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Derakhshandeh N; Abbaszadeh-Hasiri M
Top Companion Anim Med; 2020 Mar; 38():100405. PubMed ID: 32115076
[TBL] [Abstract][Full Text] [Related]
6. Prostatic hyperplasia: Vascularization, hemodynamic and hormonal analysis of dogs treated with finasteride or orchiectomy.
Angrimani DSR; Francischini MCP; Brito MM; Vannucchi CI
PLoS One; 2020; 15(6):e0234714. PubMed ID: 32584842
[TBL] [Abstract][Full Text] [Related]
7. Frozen-Thawed Sperm Analysis of Benign Prostatic Hyperplasia Dogs Treated With Finasteride.
Flores RB; Angrimani DSR; Brito MM; de Almeida LL; Lopes JVM; Losano JDA; Vannucchi CI
Front Vet Sci; 2022; 9():901943. PubMed ID: 35847633
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of finasteride and laser-irradiated silver nanoparticles on testicular function and histology in testosterone induced benign prostatic hyperplasia in rats.
Marghani BH; Ezz MA; Ateya AI; Fehaid A; Saleh RM; Rezk S
Life Sci; 2023 Jul; 324():121747. PubMed ID: 37137466
[TBL] [Abstract][Full Text] [Related]
9. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
[TBL] [Abstract][Full Text] [Related]
12. Does finasteride treatment for benign prostatic hyperplasia influence sperm DNA integrity in dogs?
Angrimani DSR; Bicudo LC; Llamas Luceño N; Rui BR; Silva MF; Losano JDA; Leemans B; Van Soom A; Vannucchi CI
Basic Clin Androl; 2020; 30():9. PubMed ID: 32695403
[TBL] [Abstract][Full Text] [Related]
13. Finasteride-induced prostatic involution by apoptosis in dogs with benign prostatic hypertrophy.
Sirinarumitr K; Sirinarumitr T; Johnston SD; Sarkar DK; Kustritz MV
Am J Vet Res; 2002 Apr; 63(4):495-8. PubMed ID: 11939309
[TBL] [Abstract][Full Text] [Related]
14. The influence of benign prostatic hyperplasia on sperm morphological features and sperm DNA integrity in dogs.
Flores RB; Angrimani D; Rui BR; Brito MM; Abreu RA; Vannucchi CI
Reprod Domest Anim; 2017 Apr; 52 Suppl 2():310-315. PubMed ID: 27774660
[TBL] [Abstract][Full Text] [Related]
15. Effect of finasteride (Proscar MSD) on seminal composition, prostate function and fertility in male dogs.
Iguer-Ouada M; Verstegen JP
J Reprod Fertil Suppl; 1997; 51():139-49. PubMed ID: 9404280
[TBL] [Abstract][Full Text] [Related]
16. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
17. The role of sex steroids in the pathogenesis and maintenance of benign prostatic hyperplasia.
Levine AC; Kirschenbaum A; Gabrilove JL
Mt Sinai J Med; 1997 Jan; 64(1):20-5. PubMed ID: 8997072
[TBL] [Abstract][Full Text] [Related]
18. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
Monti S; Sciarra F; Adamo MV; Toscano V; Trotta MC; Martini C; Lanzara S; Silverio FD
J Androl; 1997; 18(5):488-94. PubMed ID: 9349746
[TBL] [Abstract][Full Text] [Related]
19. Determination of concentrations of sex steroids in blood plasma and semen of male dogs treated with delmadinone acetate or finasteride.
Lange K; Cordes EK; Hoppen HO; Günzel-Apel AR
J Reprod Fertil Suppl; 2001; 57():83-91. PubMed ID: 11787194
[TBL] [Abstract][Full Text] [Related]
20. Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study.
Yang XJ; Lecksell K; Short K; Gottesman J; Peterson L; Bannow J; Schellhammer PF; Fitch WP; Hodge GB; Parra R; Rouse S; Waldstreicher J; Epstein JI
Urology; 1999 Apr; 53(4):696-700. PubMed ID: 10197843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]